- Home
- DSGN vs HWBK Comparison
DSGN vs HWBK Comparison
Compare DSGN & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- HWBK
- Stock Information
- Founded
- DSGN 2017
- HWBK 1865
- Country
- DSGN United States
- HWBK United States
- Employees
- DSGN N/A
- HWBK N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- HWBK Major Banks
- Sector
- DSGN Health Care
- HWBK Finance
- Exchange
- DSGN Nasdaq
- HWBK Nasdaq
- Market Cap
- DSGN 208.9M
- HWBK 218.6M
- IPO Year
- DSGN 2021
- HWBK N/A
- Fundamental
- Price
- DSGN $6.24
- HWBK $30.36
- Analyst Decision
- DSGN
- HWBK
- Analyst Count
- DSGN 0
- HWBK 0
- Target Price
- DSGN N/A
- HWBK N/A
- AVG Volume (30 Days)
- DSGN 196.1K
- HWBK 10.9K
- Earning Date
- DSGN 11-07-2025
- HWBK 10-29-2025
- Dividend Yield
- DSGN N/A
- HWBK 2.63%
- EPS Growth
- DSGN N/A
- HWBK 259.87
- EPS
- DSGN N/A
- HWBK 3.19
- Revenue
- DSGN N/A
- HWBK $77,714,000.00
- Revenue This Year
- DSGN N/A
- HWBK N/A
- Revenue Next Year
- DSGN N/A
- HWBK N/A
- P/E Ratio
- DSGN N/A
- HWBK $9.66
- Revenue Growth
- DSGN N/A
- HWBK 33.55
- 52 Week Low
- DSGN $2.60
- HWBK $25.21
- 52 Week High
- DSGN $7.77
- HWBK $35.95
- Technical
- Relative Strength Index (RSI)
- DSGN 49.22
- HWBK 50.35
- Support Level
- DSGN $6.25
- HWBK $30.07
- Resistance Level
- DSGN $6.77
- HWBK $31.03
- Average True Range (ATR)
- DSGN 0.48
- HWBK 0.66
- MACD
- DSGN 0.02
- HWBK 0.13
- Stochastic Oscillator
- DSGN 49.74
- HWBK 58.49
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.